13F-HR filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 16:47:24 UTC, with 91 holding rows worth $559,545,201.
- Accession
- 0001420506-26-002774
- Filer
- CIK 1952142
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 93 entries on the cover page, a total value of $559,545,201 stated on the cover page (in dollars after the unit check, H1), rows summing to $559,545,201 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 688,954 | $33,290,257 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,260,594 | $33,140,308 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 279,398 | $27,665,990 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 989,345 | $24,684,158 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 641,473 | $23,458,668 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 649,924 | $23,033,307 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 330,476 | $15,149,020 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 333,332 | $13,506,613 | dollars as filed | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 463,551 | $13,396,624 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 150,776 | $13,275,827 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 404,921 | $12,042,351 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 132,238 | $11,773,149 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 1,308,193 | $11,485,935 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 81,924 | $11,479,191 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 38,720 | $11,276,426 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 418,527 | $11,117,745 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 3,293,376 | $10,966,942 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,050,698 | $10,786,671 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 506,067 | $10,769,106 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 50,000 | $10,263,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 145,760 | $9,607,042 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 25,051 | $9,167,163 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 222,287 | $8,266,854 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 30,000 | $7,942,200 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 552,245 | $7,908,148 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 6,599 | $7,635,571 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 109,926 | $7,194,657 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 2,967,942 | $7,063,702 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 201,334 | $6,801,063 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 471,718 | $6,627,638 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 33,527 | $5,979,876 | dollars as filed | |
| OMNIAB INC | 68218J103 | COM | 1,204,038 | $5,972,028 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 184,173 | $5,897,219 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 396,865 | $5,298,148 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 200,000 | $5,026,000 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 123,760 | $4,754,859 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 57,880 | $4,602,618 | dollars as filed | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 195,143 | $4,581,958 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 111,577 | $4,530,026 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 2,485,233 | $4,473,419 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 2,563,862 | $4,384,204 | dollars as filed | |
| BIODESIX INC COM | 09075X207 | Stock | 141,548 | $4,222,377 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 42,200 | $4,148,260 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 99,880 | $4,118,052 | dollars as filed | |
| AURA BIOSCIENCES INC | 05153U107 | COMMON STOCK | 647,406 | $4,065,710 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 54,791 | $3,884,134 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 159,044 | $3,867,950 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 51,804 | $3,865,096 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 187,320 | $3,856,919 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 200,836 | $3,831,951 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 91,757 | $3,474,950 | dollars as filed | |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 825,000 | $3,473,250 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 118,000 | $3,361,820 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 8,087 | $3,288,417 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 137,973 | $3,271,340 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 1,287,804 | $3,206,632 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P205 | COM | 108,647 | $2,810,698 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 4,646 | $2,517,621 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 154,234 | $2,484,710 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 138,200 | $2,368,748 | dollars as filed | |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 27,260 | $2,270,485 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 19,603 | $2,237,486 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 29,275 | $2,116,583 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 66,320 | $2,103,670 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 495,980 | $1,864,885 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 23,302 | $1,856,470 | dollars as filed | |
| HELIX ACQUISITION CORP III | G4444S107 | USD CL A ORD SHS | 171,671 | $1,823,146 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 61,189 | $1,617,225 | dollars as filed | |
| AETHLON MEDICAL INC | 00808Y703 | Common Stock, $0.001 par value per share | 213,685 | $1,393,226 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 100,000 | $1,251,000 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 352,689 | $1,118,024 | dollars as filed | |
| JATT III ACQUISITION CORP | G5080G109 | COM | 100,000 | $1,102,000 | dollars as filed | |
| QUOIN PHARMACEUTICALS LTD | 74907L409 | SPONSORED ADS | 236,234 | $1,077,227 | dollars as filed | |
| ADARx Pharmaceuticals, Inc. | 00654F105 | Common Stock, par value $0.0001 per share | 52,000 | $1,036,880 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 156,663 | $990,110 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F880 | COM NEW | 447,360 | $823,142 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 21,763 | $555,609 | dollars as filed | |
| CalciMedica Inc | 38942Q301 | COM | 248,972 | $403,335 | dollars as filed | |
| INVESCO QQQ TR | 46090E103 | COM | 60,000 | $255,300 | dollars as filed | put |
| SPY | 78462F103 | SHS | 75,000 | $226,125 | dollars as filed | put |
| Braveheart Bio Inc | 10567X101 | COM | 10,000 | $202,000 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 44,129 | $166,366 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 25,000 | $143,750 | dollars as filed | call |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 10,000 | $106,500 | dollars as filed | call |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 450,000 | $102,500 | dollars as filed | put |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 75,000 | $88,125 | dollars as filed | call |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 375,000 | $71,250 | dollars as filed | put |
| Johnson & Johnson | 478160104 | COM | 30,000 | $55,500 | dollars as filed | put |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 15,000 | $52,500 | dollars as filed | put |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 337,939 | $24,716 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 45,000 | $15,750 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-002774 | this filing | 2026-11-16 |